PetMed Express Inc. stocks have been trading up by 21.43 percent amid reports of strengthening pet telehealth and e-commerce demand.
Click Here for a Millionaire's POV on Trading PETS
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Q4 EPS landed at -$0.19 for PetMed Express, a sharp improvement from -$0.56 a year earlier.
- Quarterly revenue slid to about $42.82M from $50.76M, showing PETS still battling top-line pressure.
- Management points to sequential net sales improvement and a leaner cost structure at PETS.
- New B2B and white-label efforts, including a Rural King agreement, aim to expand the PetMed Express footprint and customer retention.
Live Update At 10:03:14 EDT: On Monday, June 29, 2026 PetMed Express Inc. stock [NASDAQ: PETS] is trending up by 21.43%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
PetMed Express, trading under ticker PETS, is trying to turn a slow-moving ship. The latest quarter shows Q4 EPS at -$0.19 versus -$0.56 a year earlier, so the loss is shrinking. That matters, because it tells traders that PETS is at least tightening the screws on its operations.
Revenue, however, dropped from $50.76M to $42.82M. The key ratios back up the pain on the income side. Annual revenue sits near $179.0M, with multi‑year revenue trends down more than 10% per year. Profit margins for PETS are still deep in the red, with total profit margin around -32% and EBIT margin at about -17%.
On the balance sheet, PetMed Express shows roughly $21.4M in cash and very low debt, with total debt-to-equity near 0.02. That gives PETS some breathing room, even as operating cash flow of about -$4.7M in the recent quarter shows the turnaround is not done.
More Breaking News
- Anterix ATEX Jumps As Q4 Beat Fuels Fresh Buy Rating
- Rocket Lab Stock Rebounds As Analysts Back Space Launch Boom
- FLUT Rises As Flutter Wins Fresh Analyst Backing
- NNOX Jumps As Nano-X Imaging Signs Peru Distribution Deal
The chart hints at early momentum. Over recent days PETS has climbed from the $1.70s to above $2.10, with intraday spikes as high as the mid‑$2.40s. For short-term traders, that combination of improving EPS, heavy losses, and low price can create volatile trading setups.
Why Traders Are Watching PETS Right Now
PETS is finally giving traders something to work with. The headline number is simple: PetMed Express cut its quarterly loss per share from -$0.56 to -$0.19 while revenue fell to $42.82M from $50.76M. That’s classic turnaround math — better earnings metrics riding on a smaller sales base. For active traders, that mix often fuels sharp re-ratings when the market decides whether the story is real or just a dead‑cat bounce.
On the tape, PETS has woken up. The multi-day chart shows a grind higher from roughly $1.68–$1.75 into the low $2s, followed by a high‑range session where the stock opened around $2.23, spiked to $2.35, and then whipped between $2.00 and $2.30 all morning. Those 5‑minute candles — big wicks, fast reversals — scream day-trader playground. Liquidity is there, and so is emotion.
Under the hood, PetMed Express is trying to rewrite its playbook. Management says net sales are improving sequentially and costs are coming out of the system. The big strategic swing is on the B2B and white‑label side, with a Master Services Agreement with Rural King. For PETS, that deal is about using its pharmacy and logistics backbone to serve other brands, not just its own site. If PetMed Express can scale that kind of partnership, revenue concentration risk drops and customer reach expands without massive ad spend.
Traders will watch whether these new channels show up in future quarters as stable, recurring revenue. If EPS continues to improve and the top line stabilizes, PETS moves from “broken chart bounce” to “credible turnaround candidate” in many watchlists. If revenue keeps sliding, it stays a short-term momentum trade instead of a longer narrative.
Conclusion
Right now, PETS sits at an interesting crossroads. PetMed Express has proven it can narrow losses — Q4 EPS at -$0.19 against -$0.56 a year ago is no small shift — but the revenue line at $42.82M versus $50.76M says demand has not recovered yet. The financials show a company with decent cash, minimal debt, and negative but improving cash flow. That combo often attracts traders who specialize in beaten-down names with real, but risky, turnaround potential.
The Rural King Master Services Agreement adds a fresh angle. If PetMed Express can turn B2B and white‑label work into a steady pipeline, PETS may not be as dependent on its legacy direct‑to‑consumer model. For chart-focused traders, the recent push from the mid‑$1.70s into the low $2s, plus the intraday swings above $2.30, signal rising interest and volatility — the raw material for both day trades and short swings. As Tim Bohen, lead trainer with StocksToTrade says, “For me, trading is more about managing risk than finding the next big mover.” That risk‑first mindset is especially relevant when dealing with volatile small‑cap turnaround plays like PETS.
As Tim Sykes likes to remind his community, “Patterns repeat, but only for traders who study hard and cut losses quickly.” PETS is another test case of that mindset. Study the earnings trend, track how the Rural King partnership flows into future numbers, and let the price action confirm or deny the story. This is educational and research material, not a buy or sell call — but for disciplined traders, PetMed Express belongs on the radar.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.